Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
Dopram Injection.
Doxapram Hydrochloride 20mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Sterile solution for intravenous injection. |
Dopram Injection contains 20mg Doxapram Hydrochloride BP per ml.
| Active Ingredient | Description | |
|---|---|---|
| Doxapram |
Doxapram is an analeptic agent (a stimulant of the central nervous system). Doxapram produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. It is thought to stimulate the carotid body by inhibiting certain potassium channels. Used as temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease. |
| List of Excipients |
|---|
|
Water for Injections |
Primary container: Clear type I one point-cut (OPC) glass ampoules
Secondary container: Cardboard carton
Presentation: Each ampoule contains 5ml
Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0573
20/03/2006
| Drug | Countries | |
|---|---|---|
| DOPRAM | France, Japan, Malta, Netherlands, Romania, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
